| 11834412 |
Derivatives of aryl hydrocarbon receptor agonists |
Matthew Gene Davidson, Julie Saiki, Steven R. Schow |
2023-12-05 |
| 8361971 |
Tablet formulation of ezatiostat |
Stephan D. Parent, Chunsheng Qiao, Steven R. Schow |
2013-01-29 |
| 7109330 |
Purine inhibitors of cyclin dependent kinase 2 and IκB-α |
Cheri Blum, Richard L. Mackman, Michael M. Wick, Steven R. Schow, Jeff Zablocki +1 more |
2006-09-19 |
| 7071231 |
Naphthalene ureas as glucose uptake enhancers |
Wayne Spevak, Songyuan Shi, Prasad Manchem, Michael R. Kozlowski, Steven R. Schow |
2006-07-04 |
| 7029695 |
Therapeutic compositions containing glutathione analogs |
Thomas Redelmeier, Lawrence M. Kauvar, Matthew H. Lyttle, Robert W. Macsata, Steven R. Schow +2 more |
2006-04-18 |
| 6794390 |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha |
Cheri Blum, Richard L. Mackman, Michael M. Wick, Steven R. Schow |
2004-09-21 |
| 6790958 |
Purine inhibitors of cyclin dependent kinase 2 & IKBA |
Cheri Blum, Richard L. Mackman, Michael M. Wick, Steven R. Schow, Jeffery A. Zablocki +1 more |
2004-09-14 |
| 6781000 |
Alpha-ketoamide inhibitors of 20S proteasome |
Lisa Wang, Steven R. Schow, Alison Joly, Suresh S. Kerwar, Michael M. Wick |
2004-08-24 |
| 6653321 |
Naphthylsulfonic acids and related compounds as glucose uptake agonists |
Wayne Spevak, Songyuan Shi, Prasad Manchem, Michael R. Kozlowski, Steven R. Schow +2 more |
2003-11-25 |
| 6528037 |
Method for determining whether a compound is an insulin receptor kinase activator |
Prasad Manchem, Steven R. Schow |
2003-03-04 |
| 6506739 |
Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents |
R. Jason Herr, Steven R. Schow, Fanying Meng, Michael R. Kozlowski, Pavel E. Zhichkin |
2003-01-14 |
| 6479548 |
Substituted stilbenes as glucose uptake enhancers |
John W. Patterson, Sophia Park, Wayne Spevak |
2002-11-12 |
| 6458998 |
Naphthalene ureas as glucose uptake enhancers |
Wayne Spevak, Songyuan Shi, Prasad Manchem, Michael R. Kozlowski, Steven R. Schow |
2002-10-01 |
| 6337338 |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
Michael R. Kozlowski, Steven R. Schow, Hugo O. Villar, Micheal M. Wick |
2002-01-08 |
| 6117887 |
Inhibition of 26S and 20S proteasome by indanones |
Steven R. Schow, Alison Joly, Suresh S. Kerwar, Marek G. Nelson, Michael M. Wick |
2000-09-12 |
| 6075150 |
.alpha.-ketoamide inhibitors of 20S proteasome |
Lisa Wang, Steven R. Schow, Alison Joly, Suresh S. Kerwar, Michael M. Wick |
2000-06-13 |
| 5866702 |
Purine inhibitors of cyclin dependent kinase 2 |
Richard L. Mackman, Steven R. Schow, Michael M. Wick |
1999-02-02 |
| 5834487 |
Inhibition of 26S and 20S proteasome by indanones |
Steven R. Schow, Alison Joly, Suresh S. Kerwar, Marek G. Nelson, Michael M. Wick |
1998-11-10 |
| 5789416 |
N.sup.6 mono heterocyclic substituted adenosine derivatives |
Jurg R. Pfister, Steven R. Schow, Michael M. Wick, Marek G. Nelson, George F. Schreiner |
1998-08-04 |
| 5656660 |
Compositions and methods for treating mast-cell mediated conditions |
Heinz W. Gschwend, Barr E. Bauer, Elaine Yee-Lin Kuo, Ken Rice |
1997-08-12 |